down up

Kazia Therapeutics (KZA) CEO & Managing Director, Dr James Garner

30 November 2017 1min read

PREVIOUS ARTICLE Perth to test driverless Uber ... NEXT ARTICLE Aust shares look set to open l...

Executive Series: Kazia Therapeutics (KZA) CEO & Managing Director, Dr James Garner In this short video, Tom & James discuss; • Kazia’s recent name change from Novogen
• Progress of its ovarian cancer and brain cancer drug trials YouTube Link: https://youtu.be/Pd55l3EC66A To view more Executive Series interviews, visit:https://www.commsec.com.au/market-news/executive-series

Top 30 shorted stocks

The technique of profiting from a price fall is called …

Resources

“Are We Entering the Golden Age of Gas?”

That question was posed in the title of a 2011 …

Trends & Opportunities

Gold Selloff Risk is High

Gold surged dramatically in recent weeks, powering higher to a …

Best Resources & Offers

City Index

Well established Beginner friendly Free webinars Regulated: ASIC FCA Platforms: Advantage Web AT Pro MT4 WebTrader

eToro

• Social and Copy Trading Platform
• Crypto, CFDs, Forex, Stocks
• 24/5 Customer Support
• Beginner Friendly
• ASIC, CySEC, FCA regulated

FPMARKETS

– АSIC Regulated
– True ECN Execution with spreads from 0.0 pips
– Powerful 500:1 leverage and 0.01 micro lot trading
– Scalping, hedging and EAs are allowed – MAM / PAMM accounts
– Established in 2005
– 10,000+ products to trade

AVATRADE

40% New Member Bonus
– MIFID, ASIC, FSA & FSCA regulated
– Free Online Trading Coach

XM TRADING

50% first time deposit Bonus up to $5000
ASIC, FCA, CySEC regulated
Minimum deposit $5

SAXOBANK

The no. 1 choice for active traders* -35,000+ instruments from account -Award-winning trading platforms -Industry-leading prices -24/5 tailored expert service -Global financial institution with local expertise *Best platform for Active Trader, 2017 ADVFN International Financial Awards